Physician profile
Claudia J House
NPI 1386772200
$808.89
in general payments reported to CMS, 2019-2025
5 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Occupational Vision provider received nationally (typical 2025 total: $169).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.51 · 2021: $137 · 2022: $22.59 · 2023: $387 · 2024: $127 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $634.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $382.17 | 2023-2024 | Infuse, Ultra Multifocal Toric, Infuse Multifocal |
| Alcon Vision LLC | $148.30 | 2021-2025 | Precision7, Precision 1 |
| Oyster Point Pharma, INC. | $138.91 | 2022-2023 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia House listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.